Indoramin
CARDIOVASCULAR SYSTEM
Also known as: indoramine, Wy 21901, Wy-21901, Wy21901
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Indoramin is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1981. DrugCentral lists 11 molecular targets, including ADRA1A, ADRA1A and DRD4.
- Molecular targets: ADRA1A, ADRA1A, DRD4 and Adra1b|Adra1d|Adra1a (11 listed in DrugCentral).
- ATC code: C02CA02 (Alpha-adrenoreceptor antagonists).
- Molecular formula: C22H25N3O; molecular weight 347.46 g/mol.
Mechanism & targets
Molecular targets (11)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Alpha-1A adrenergic receptor | ADRA1A | unknown | Ki 8.43 |
| Alpha-1A adrenergic receptor | ADRA1A | unknown | Ki 7.92 |
| D(4) dopamine receptor | DRD4 | unknown | Ki 7.75 |
| Adrenergic receptor alpha-1 | Adra1b|Adra1d|Adra1a | unknown | Ki 7.61 |
| Alpha-1B adrenergic receptor | ADRA1B | unknown | Ki 7.60 |
| Alpha-1D adrenergic receptor | ADRA1D | unknown | Ki 6.96 |
| Alpha-2C adrenergic receptor | ADRA2C | unknown | Ki 6.32 |
| Alpha-2B adrenergic receptor | ADRA2B | unknown | Ki 6.28 |
| Alpha-1D adrenergic receptor | Adra1d | unknown | Ki 6.21 |
| Alpha-2A adrenergic receptor | ADRA2A | unknown | Ki 5.65 |
| Adrenergic receptor alpha-2 | Adra2b|Adra2c|Adra2a | unknown | Ki 4.92 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1981-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C02CA02 | CARDIOVASCULAR SYSTEM › ANTIHYPERTENSIVES › ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING › Alpha-adrenoreceptor antagonists |
Chemical structure
| Molecular formula | C22H25N3O |
|---|---|
| Molecular weight | 347.46 g/mol |
| CAS number | 26844-12-2 |
| InChIKey | JXZZEXZZKAWDSP-UHFFFAOYSA-N |
| PubChem CID | 33625 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Indoramin work?
Its molecular targets in DrugCentral include ADRA1A, ADRA1A, DRD4 and Adra1b|Adra1d|Adra1a.
When was Indoramin first approved?
Indoramin was first approved by the YEAR INTRODUCED in 1981.
What is the chemical formula of Indoramin?
Indoramin has the molecular formula C22H25N3O and a molecular weight of 347.46 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1443 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL279516 — compound record and bioactivity
- PubChem CID 33625 — chemical identifiers
- DrugBank DB08950 — drug record
- FDA UNII 0Z802HMY7H — substance identity
- UniProt P35348 (ADRA1A) — target protein
- UniProt P21917 (DRD4) — target protein
- UniProt P35368 (ADRA1B) — target protein
- UniProt P25100 (ADRA1D) — target protein
- UniProt P18825 (ADRA2C) — target protein
- UniProt P18089 (ADRA2B) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.